Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma

This study has been completed.
Information provided by (Responsible Party):
Ming-Lung Yu, Kaohsiung Medical University Chung-Ho Memorial Hospital Identifier:
First received: February 26, 2008
Last updated: September 3, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)